ed (I) May be waived (') PK/PD Rigorous comparative PK study to listed reference drug Rigorous comparative PK studies to listed reference drug Immunogenicity Data Comparative data (2) Comparative data (2) Efficacy from Clinical trials Efficacy data required (3) (immunogenicity data can be obtained simulta